M. Davies

发表

The first de novo designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.

Timo Heikkilae, S. Thirumalairajan, M. Davies, 2006, Bioorganic & medicinal chemistry letters.

Approaches to the rational design of molecularly imprinted polymers

M. Davies, D. Perrett, V. Biasi, 2004 .

In Silico Screening and In Vitro Evaluation of GSK-3β Type I and II Inhibitors: Potential Treatment for Alzheimer’s Disease?

M. Davies, 2019 .

Identification of binding residues between periplasmic adapter protein (PAP) and RND efflux pumps explains PAP-pump promiscuity and roles in antimicrobial resistance

M. Davies, M. Webber, V. Bavro, 2019, PLoS pathogens.

The affinity of bacterial polysaccharide-containing fractions for mammalian cell membranes and its relationship to immunopotentiating activity.

M. Davies, D. Stewart-Tull, 1981, Biochimica et biophysica acta.

Design and synthesis of potent inhibitors of the malaria parasite dihydroorotate dehydrogenase.

Timo Heikkilae, M. Davies, C. Fishwick, 2007, Journal of medicinal chemistry.

Identification of C-β-d-Glucopyranosyl Azole-Type Inhibitors of Glycogen Phosphorylase That Reduce Glycogenolysis in Hepatocytes: In Silico Design, Synthesis, in Vitro Kinetics, and ex Vivo Studies.

Z. Al-Oanzi, M. Davies, T. Snape, 2019, ACS chemical biology.

The binding of lipopolysaccharide from Escherichia coli to mammalian cell membranes and its effect on liposomes.

M. Davies, D. Jackson, D. Stewart-Tull, 1978, Biochimica et biophysica acta.

Bacillus Calmette-Guérin as an anti-tumor agent. The interaction with cells of the mammalian immune system.

M. Davies, Martin Davies, 1982, Biochimica et biophysica acta.

Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate.

M. Davies, T. Rosenberry, A. Fauq, 2003, Biochemistry.

Structure-Based Design of Potent Selective Nanomolar Type-II Inhibitors of Glycogen Synthase Kinase-3β.

M. Davies, C. Pérez, Ana Martínez, 2021, Journal of medicinal chemistry.

Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases.

M. Davies, M. R. Parsons, C. Fishwick, 2009, Journal of medicinal chemistry.

Immunology of the bacterial cell envelope

M. Davies, D. Stewart-Tull, 1985 .

Derivatives of pyrimidine, phthalimide and anthranilic acid as inhibitors of human hydroxysteroid dehydrogenase AKR1C1.

M. Davies, C. Fishwick, A. Johnson, 2009, Chemico-biological interactions.

Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism.

J Milner, M. Davies, P. Hainaut, 1995, Oncogene.